Harnessing machine learning for development of microbiome therapeutics.

Area of Science:

• Microbiome research
• Artificial intelligence
• Drug discovery

Background:

• Seminal research over 20 years highlights the microbiome's critical role in human health.
• An imbalanced microbiome is increasingly linked to various diseases, generating substantial big data.
• Machine learning (ML) provides advanced analytical capabilities for complex biological datasets.

Purpose of the Study:

• To explore the application of ML in developing microbiome-targeted therapeutics.
• To provide a guide to microbiome big data resources.
• To discuss current and future opportunities for ML in microbiome therapeutics.

Main Methods:

• Review of existing literature on ML applications in microbiome research.
• Discussion of ML techniques for data analysis and prediction.
• Exploration of ML for discovering, designing, and characterizing therapeutics.

Main Results:

• ML can analyze vast microbiome datasets to identify therapeutic targets.
• ML aids in the discovery and design of novel microbiome-based drugs.
• ML can optimize advanced processes like 3D printing and in silico drug-microbiome interaction prediction.

Conclusions:

• ML is a powerful tool for advancing microbiome-targeted therapeutics.
• Addressing barriers to ML adoption is crucial for future progress.
• The integration of ML promises significant innovation in microbiome medicine.